Contineum Therapeutics phase 2 PIPE-307 VISTA trial to treat RRMS fails to meet its prespecified primary or secondary efficacy endpoints: San Diego Saturday, November 22, 2025, 18 ...
US FDA grants priority review for Alexion's sBLA for Soliris to treat atypical Haemolytic Uremic Syndrome: Cheshire Connecticut Friday, June 3, 2011, 17:00 Hrs [IST] Alexion Pharm ...
BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform: Vancouver, BC Saturday, November 22, 2025, 17:00 Hrs [IST] BioNxt Solutions Inc. (BioNxt), a bioscien ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback